Please login to the form below

Not currently logged in
Email:
Password:

Dayvigo

This page shows the latest Dayvigo news and features for those working in and with pharma, biotech and healthcare.

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Since then, it’s been joined on the market by Eisai’s recently-approved Dayvigo (lemborexant), which is also being tested in Alzheimer’s-relate sleep disturbances and reported positive results

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...

Infographics